Zai Lab (ZLAB) Other Non-Current Assets (2016 - 2026)
Zai Lab (ZLAB) posted Other Non-Current Assets of $3.2 million for Q1 2026, up 3.73% sequentially from $3.1 million in Q4 2025, and up 25.02% YoY from $2.5 million in Q1 2025.
Zai Lab (ZLAB) Other Non-Current Assets (2016 - 2026) Analysis & Trends
Zai Lab has reported Other Non-Current Assets for 11 years, with the latest figure at $3.2 million in Q1 2026.
- Quarterly Other Non-Current Assets rose 25.02% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (up 25.02% YoY) and the FY2025 annual result came in at $3.1 million, down 47.05% from the prior year.
- Other Non-Current Assets improved to $3.2 million in Q1 2026 per ZLAB's latest filing, from $3.1 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $5.8 million in Q4 2024 and troughed at $803000.0 in Q1 2022.
- A 5-year average of $2.0 million and a median of $1.5 million in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets soared 377.09% in 2024, then plunged 47.05% in 2025.
- Over 5 years, Other Non-Current Assets stood at $1.4 million in 2022, then declined by 13.4% to $1.2 million in 2023, then jumped by 377.09% to $5.8 million in 2024, then slumped by 47.05% to $3.1 million in 2025, then advanced by 3.73% to $3.2 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $3.2 million, $3.1 million, and $2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 3.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.54 Mn |
| Mar 31, 2026 | 3.17 Mn |
| Dec 31, 2025 | 3.05 Mn |
| Sep 30, 2025 | 2.13 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | 2.53 Mn |
| Dec 31, 2024 | 5.77 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Mar 31, 2023 | 1.32 Mn |
| Dec 31, 2022 | 1.40 Mn |
| Sep 30, 2022 | 803,000.00 |
| Jun 30, 2022 | 803,000.00 |
| Mar 31, 2022 | 803,000.00 |
| Dec 31, 2021 | 803,000.00 |
| Sep 30, 2021 | 743,000.00 |